Simona Mancini

Via Cadore 48
Monza, 20900, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

The ability of liposomes, tailored for blood-brain barrier targeting, to reach the brain is dramatically affected by the disease state.

The ability of liposomes, tailored for blood-brain barrier targeting, to reach the brain is dramatically affected by the disease state.

Journal: Nanomedicine (London, England)

Published: January 30, 2018

Functionalized liposomes and phytosomes loading Annona muricata L. aqueous extract: Potential nanoshuttles for brain-delivery of phenolic compounds.

Functionalized liposomes and phytosomes loading Annona muricata L. aqueous extract: Potential nanoshuttles for brain-delivery of phenolic compounds.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: November 02, 2017

Multifunctional liposomes delay phenotype progression and prevent memory impairment in a presymptomatic stage mouse model of Alzheimer disease.

Multifunctional liposomes delay phenotype progression and prevent memory impairment in a presymptomatic stage mouse model of Alzheimer disease.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: March 10, 2017

Retro-inverso peptide inhibitor nanoparticles as potent inhibitors of aggregation of the Alzheimer's Aβ peptide.

Retro-inverso peptide inhibitor nanoparticles as potent inhibitors of aggregation of the Alzheimer's Aβ peptide.

Journal: Nanomedicine : nanotechnology, biology, and medicine

Published: August 06, 2016

The cell-permeable Aβ1-6A2VTAT(D) peptide reverts synaptopathy induced by Aβ1-42wt.

The cell-permeable Aβ1-6A2VTAT(D) peptide reverts synaptopathy induced by Aβ1-42wt.

Journal: Neurobiology of disease

Published: October 19, 2015

The hunt for brain Aβ oligomers by peripherally circulating multi-functional nanoparticles: Potential therapeutic approach for Alzheimer disease.

The hunt for brain Aβ oligomers by peripherally circulating multi-functional nanoparticles: Potential therapeutic approach for Alzheimer disease.

Journal: Nanomedicine : nanotechnology, biology, and medicine

Published: June 03, 2015

Nanomedicine for the treatment of Alzheimer's disease.

Nanomedicine for the treatment of Alzheimer's disease.

Journal: Nanomedicine (London, England)

Published: May 02, 2015

Multifunctional liposomes reduce brain β-amyloid burden and ameliorate memory impairment in Alzheimer's disease mouse models.

Multifunctional liposomes reduce brain β-amyloid burden and ameliorate memory impairment in Alzheimer's disease mouse models.

Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience

Published: October 17, 2014

Soluble Aβ oligomer-induced synaptopathy: c-Jun N-terminal kinase's role.

Soluble Aβ oligomer-induced synaptopathy: c-Jun N-terminal kinase's role.

Journal: Journal of molecular cell biology

Published: April 23, 2013

Showing 1-9 of 9

Last Updated: 09/26/2026